ZimVie Inc. (ZIMV)

Market Cap	396.32M
Revenue (ttm)	451.29M
Net Income (ttm)	-348.91M
Shares Out	27.60M
EPS (ttm)	-12.84
PE Ratio	n/a
Forward PE	21.24
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102,081
Open	14.66
Previous Close	14.65
Day's Range	14.34 - 14.72
52-Week Range	7.78 - 22.40
Beta	1.99
Analysts	Hold
Price Target	18.33 (+27.65%)
Earnings Date	Oct 30, 2024

About ZIMV

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. It operates through The Dental Segment. The company offers dental implant systems; biomaterials; prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membran...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Employees: 2,600
• Stock Exchange: NASDAQ
• Ticker Symbol: ZIMV
• Website: https://www.zimvie.com

Financial Performance

In 2023, ZimVie's revenue was $457.43 million, a decrease of -1.26% compared to the previous year's $463.29 million. Losses were -$393.28 million, 515.6% more than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for ZIMV stock is "Hold." The 12-month stock price forecast is $18.33, which is an increase of 27.65% from the latest price.

Price Target

$18.33

(27.65% upside)

Analyst Consensus: Hold